What did Sanara MedTech Inc. pay for Scendia Biologics?

Sanara MedTech Inc. acquired Scendia Biologics for $10.4M in 2022, equivalent to 0.90x revenue. Target revenue was approximately $11.0M.

What does Scendia Biologics do?

Scendia Biologics is a medical devices business.

What multiple did Sanara MedTech Inc. pay for Scendia Biologics?

0.90x revenue, based on disclosed deal value of $10.4M and disclosed financials.

M&A TRANSACTION · 2022

Scendia Biologics acquired by Sanara MedTech Inc.

$10.4M· 0.90x revenue

Target

Scendia Biologics

Acquirer

Sanara MedTech Inc.

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$11.0M

EBITDA

—

Deal Value

$10.4M

EV/EBITDA

—

Context

This $10.4M acquisition of Scendia Biologics by Sanara MedTech Inc. sits in the medical devices sub-vertical. Sanara MedTech Inc. is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.

Source

Data sourced from SEC filings and press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Scendia Biologics acquisition.

Citation: ExitValue.ai. (2022). Scendia Biologics acquired by Sanara MedTech Inc.. https://exitvalue.ai/deals/scendia-biologics-acquired-by-sanara-medtech-inc-hc-2022-0064